GlaxoSmithKline is racing to be the first on the market with a new approach to treating severe asthma, filing U.S. and European applications for the injectable mepolizumab as it jockeys with Teva and AstraZeneca.

…read more

Source: GlaxoSmithKline heads to the FDA with its next big respiratory bet


0 No comments